generics

Novartis division closing Broomfield operations
Novartis division closing Broomfield operations
Broomfield Enterprise, Colorado
Novartis
drug manufacturing
Sandoz
generics
Flag link:
Nocebo effect: new interesting research
Nocebo effect: new interesting research
GoinPharma
side effects
generics
placebo effect
nocebo effect
Flag link:
With a year left before generics hit, Pfizer nabs FDA approval for new-and-improved Lyrica
With a year left before generics hit, Pfizer nabs FDA approval for new-and-improved Lyrica
Fierce Pharma
Pfizer
FDA
Lyrica
generics
Lyrica CR
shingles
diabetic peripheral neuropathy
Flag link:
BioDelivery Sciences, Teva settle patent fight over opioid dependence treatment
BioDelivery Sciences, Teva settle patent fight over opioid dependence treatment
Drug Delivery Business News
BioDelivery Sciences
Teva Pharmaceutical
opioid addiction
opioids
Bunavail
generics
Flag link:
Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff: analyst
Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff: analyst
Fierce Pharma
Teva Pharmaceutical
Mylan Labs
Copaxone
drug discounts
generics
Flag link:
FDA’s Getting a Complex
FDA’s Getting a Complex
FDA Law Blog
FDA
generics
complex drugs
Flag link:
3 Drug Stocks That Soared This Week
3 Drug Stocks That Soared This Week
Motley Fool
Endocyte
PSMA-617
MannKind
Afrezza
Mylan Labs
generics
Teva Pharmaceutical
Flag link:
Lilly wards off another Alimta patent challenge, this time through IPR
Lilly wards off another Alimta patent challenge, this time through IPR
Fierce Pharma
Eli Lilly
Alimta
patents
IPR
lung cancer
Neptune
generics
Novartis
Sandoz
Flag link:
FDA’s Gottlieb pushes new generics rules to encourage price competition
FDA’s Gottlieb pushes new generics rules to encourage price competition
Fierce Pharma
FDA
Scott Gottlieb
generics
competition
Flag link:
[video+transcript]The Creative Ways Drugmakers Are Delaying Generics
[video+transcript]The Creative Ways Drugmakers Are Delaying Generics
Motley Fool
generics
Flag link:
AbbVie's Unfazed by the Risk of Generic Humira
AbbVie's Unfazed by the Risk of Generic Humira
Motley Fool
AbbVie
generics
Humira
Flag link:
Generics Industry Calls FDA Draft Guidance on Priority Reviews 'Basically Inoperable'
Generics Industry Calls FDA Draft Guidance on Priority Reviews 'Basically Inoperable'
RAPS.org
generics
FDA
priority review
Flag link:
With U.S. Generic Drug Market in Chaos, Indian Upstarts Rise
With U.S. Generic Drug Market in Chaos, Indian Upstarts Rise
Bloomberg
generics
India
Flag link:
Allergan heads to federal court to defend Restasis against early generic rivals
Allergan heads to federal court to defend Restasis against early generic rivals
Fierce Pharma
Allergan
Restasis
generics
Mylan Labs
Teva Pharmaceutical
Akorn
InnoPharma
Flag link:
5 Important Healthcare Predictions For 2018
5 Important Healthcare Predictions For 2018
Forbes
specialty diseases
M&A
generics
technology
Asia
Flag link:
Mylan Can Focus on New Generics After EpiPen Medicaid Settlement
Mylan Can Focus on New Generics After EpiPen Medicaid Settlement
TheStreet.com
Mylan Labs
generics
EpiPens
Medicaid
Flag link:
Sun's profit crushed as it pays $150M to settle Provigil pay-for-delay case
Sun's profit crushed as it pays $150M to settle Provigil pay-for-delay case
Fierce Pharma
Sun Pharma
Provigil
pay-for-delay
generics
Mylan Labs
Flag link:
Teva kept quiet for weeks on forthcoming generics blow: report
Teva kept quiet for weeks on forthcoming generics blow: report
Fierce Pharma
Teva Pharmaceutical
generics
Flag link:
Mylan points finger at FDA for failure to win nods on Advair, Copaxone copies
Mylan points finger at FDA for failure to win nods on Advair, Copaxone copies
Fierce Pharma
Mylan Labs
FDA
Advair
Copaxone
generics
Teva Pharmaceutical
GSK
Flag link:
Spurred by Gottlieb, FDA on track to the most generic drug OKs ever in 1 year
Spurred by Gottlieb, FDA on track to the most generic drug OKs ever in 1 year
Endpoints
FDA
generics
Scott Gottlieb
Flag link: